ENHO and obesity due to melanocortin 4 receptor deficiency: Extensive research has primarily focused on the role of adropin in obesity, glucose and lipid metabolism, cardiovascular diseases, liver disease, reproductive health, and cancer, with particular emphasis on its role in energy homeostasis due to its multiple actions in improving metabolic disorders [5,10].